News and blogs
162 results found.
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
Vaccine Collaborative announce further funding for vaccine efficacy research
Find out more about the increased funding into Covid vaccine efficacy research by the Blood Cancer Vaccine Research Collaborative.
We believe we can beat blood cancer within a generation - Fatima Sulaiman.
Fatima Sulaiman, Head of Research, talks about the future of blood cancer research for us as an organisation, and what we’re doing to prioritise research.
Funding for 9 blood cancer research projects announced
Find out about how Blood Cancer UK is funding 9 research projects to help people with blood cancer, including children with Schwachman-Diamond syndrome and lymphoma.
What do covid antibody test results mean for people with blood cancer?
What do covid antibody test results mean for people with blood cancer?
I felt like I'd hit the jackpot: My experiences on a clinical trial
Learn more about Nicky's experience of taking part in a blood cancer clinical trial to treat chronic lymphocytic leukaemia (CLL) .
Together we're investing £800K in vaccine efficacy research
Read more about the Blood Cancer UK Vaccine Research Collaborative's research on Covid vaccine effectiveness in people with blood cancer.
Announcement on the first blood cancer vaccine efficacy research funding
Read Blood Cancer UK's announcement on funding the first research into COVID-19 vaccine efficacy for people with blood cancer.
What else can we use to protect people with blood cancer from covid?
Find out what Professor Andrew Ustianowski thinks can protect people with blood cancer from Covid-19.
Do people with myeloma have an antibody response to the Covid vaccine?
Read Blood Cancer UK's article on the study into the number of people with myeloma who had some kind of antibody response to the Covid vaccine.
Covid vaccine efficacy for blood cancer research collaborative launched
Find out more about The Blood Cancer UK Vaccine Research Collaborative and how it will research into Covid vaccine efficacy for blood cancer.
Deciding to take part in a chronic lymphocytic leukaemia (CLL) clinical trial - David's story
Read how the progression of David's CLL was reversed by taking ibrutinib as part of a blood cancer clinical trial.
How can I get involved in blood cancer research?
Find out how you can get involved in blood cancer research to help us beat blood cancer.
The COVID-19 vaccine and blood cancer
Blood Cancer UK responds to study conducted around the COVID-19 vaccine and blood cancer.
First study on vaccine effectiveness in people with cancer
Read Blood Cancer UK's response to the first study on Covid vaccine effectiveness in people with cancer.
Should people with blood cancer get an antibody test?
Read more about what people with blood cancer should know about antibody tests and the Covid vaccine.
Professor Jim Allan's research on CLL (chronic lymphocytic leukaemia)
Watch Blood Cancer UK's video which takes a look at Professor Jim Allan's research into treatments for CLL.
Antibiotic could help treat MLL-AML
Discover how research by Cancer Research UK and Blood Cancer UK found an antibiotic could treat a type acute myeloid leukaemia (AML).
